ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer
Photo by Wengang Zhai on Unsplash

ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer

The American Society of Clinical Oncology (ASCO) held its ASCO Gastrointestinal Cancers Symposium from January 18-20, 2024. During the Symposium, doctors, researchers, scientists, and other stakeholders discussed innovative science and…

Continue Reading ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer